Bronchoalveolar lavage cell pattern from healthy human lung

Clinical and Experimental Immunology

Volumn 167, Issue 3, 2012, Pages 523-531

  Heron, M ^a,b   Grutters, J C ^a,c   Ten Dam Molenkamp, K M ^b   Hijdra, D ^a,b   Van Heugten Roeling, A ^b   Claessen, A M E ^b   Ruven, H J T ^b   Van den Bosch, J M M ^a,c   Van Velzen Blad, H ^b  

^a Center for Interstitial Lung Diseases   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Activation markers; Age; Bronchoalveolar lavage; Differential cell counts; Lymphocyte subsets; Reference values

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; ATOPY; BLOOD ANALYSIS; CALCULATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LEUKOCYTE DIFFERENTIAL COUNT; LUNG LAVAGE; LYMPHOCYTE SUBPOPULATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SMOKING;

ADOLESCENT; ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CD4-CD8 RATIO; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; LEUKOCYTE COUNT; LUNG; LUNG DISEASES, INTERSTITIAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; REFERENCE VALUES; SMOKING; YOUNG ADULT;

EID: 84856407842     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04529.x     Document Type: Article

References (41)

1. Costabel U, Guzman J. Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med 2001; 7:255-61.
2. Heron M, Slieker WA, Zanen P etal. Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis. Clin Immunol 2008; 126:338-44.
3. Meyer KC. The role of bronchoalveolar lavage in interstitial lung disease. Clin Chest Med 2004; 25:637-49.
4. Cordeiro CR, Jones JC, Alfaro T, Ferreira AJ. Bronchoalveolar lavage in occupational lung diseases. Semin Respir Crit Care Med 2007; 28:504-13.
5. Meyer KC. Bronchoalveolar lavage as a diagnostic tool. Semin Respir Crit Care Med 2007; 28:546-60.
6. Fan LL, Lung MC, Wagener JS. The diagnostic value of bronchoalveolar lavage in immunocompetent children with chronic diffuse pulmonary infiltrates. Pediatr Pulmonol 1997; 23:8-13.
7. Costabel U, Guzman J, Bonella F, Oshimo S. Bronchoalveolar lavage in other interstitial lung diseases. Semin Respir Crit Care Med 2007; 28:514-24.
8. Martin RJ, Coalson JJ, Rogers RM, Horton FO, Manous LE. Pulmonary alveolar proteinosis: the diagnosis by segmental lavage. Am Rev Respir Dis 1980; 121:819-25.
9. Reynolds HY, Newball HH. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med 1974; 84:559-73.
10. van den Bosch JM, van Helden HP. Bronchoalveolar lavage, a new study method. I. Findings in healthy volunteers. Ned Tijdschr Geneeskd 1983; 127:587-90.
11. Balbi B, Pignatti P, Corradi M etal. Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults. Eur Respir J 2007; 30:769-81.
12. Kolopp-Sarda MN, Kohler C, De March AK, Bene MC, Faure G. Discriminative immunophenotype of bronchoalveolar lavage CD4 lymphocytes in sarcoidosis. Lab Invest 2000; 80:1065-9.
13. (+)CD28(null) cells? Clin Exp Immunol 2009; 160:256-65.
14. Keogh BA, Crystal RG. Alveolitis: the key to the interstitial lung disorders. Thorax 1982; 37:1-10.
15. Luzina IG, Todd NW, Iacono AT, Atamas SP. Roles of T lymphocytes in pulmonary fibrosis. J Leukoc Biol 2008; 83:237-44.
16. Sakaguchi S, Sakaguchi N, Shimizu J etal. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182:18-32.
17. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 2006; 173:803-10.
18. Hartl D, Koller B, Mehlhorn AT etal. Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 2007; 119:1258-66.
19. Smyth LJ, Starkey C, Vestbo J, Singh D. CD4-regulatory cells in COPD patients. Chest 2007; 132:156-63.
20. Johansson SG, Bieber T, Dahl R etal. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113:832-6.
21. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group. Eur Respir J 1989; 2:561-85.
22. Burke WM, Roberts CM, Bryant DH etal. Smoking-induced changes in epithelial lining fluid volume, cell density and protein. Eur Respir J 1992; 5:780-4.
23. Costabel U, Guzman J. Effect of smoking on bronchoalveolar lavage constituents. Eur Respir J 1992; 5:776-9.
24. Drent M, Mansour K, Linssen C. Bronchoalveolar lavage in sarcoidosis. Semin Respir Crit Care Med 2007; 28:486-95.
25. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis 1990; 141:S169-S202.
26. Costabel U, Bross KJ, Reuter C, Ruhle KH, Matthys H. Alterations in immunoregulatory T-cell subsets in cigarette smokers. A phenotypic analysis of bronchoalveolar and blood lymphocytes. Chest 1986; 90:39-44.
27. Comans-Bitter WM, de Groot R, van den Beemd R etal. Reference values for lymphocyte subpopulations in blood. In: van Dongen JJM, Hooijkaas H, eds. Flowcytometric immunodiagnostics. New developments and their applications. Rotterdam, the Netherlands: Erasmus University, 1998:134-40.
28. Dohn MN, Baughman RP. Effect of changing instilled volume for bronchoalveolar lavage in patients with interstitial lung disease. Am Rev Respir Dis 1985; 132:390-2.
29. Rennard SI, Ghafouri M, Thompson AB etal. Fractional processing of sequential bronchoalveolar lavage to separate bronchial and alveolar samples. Am Rev Respir Dis 1990; 141:208-17.
30. Meyer KC, Soergel P. Variation of bronchoalveolar lymphocyte phenotypes with age in the physiologically normal human lung. Thorax 1999; 54:697-700.
31. Drent M, van Velzen-Blad H, Diamant M, Wagenaar SS, Donckerwolck-Bogaert M, van den Bosch JM. Differential diagnostic value of plasma cells in bronchoalveolar lavage fluid. Chest 1993; 103:1720-4.
32. Pohunek P, Pokorna H, Striz I. Comparison of cell profiles in separately evaluated fractions of bronchoalveolar lavage (BAL) fluid in children. Thorax 1996; 51:615-18.
33. Thompson AB, Bohling T, Payvandi F, Rennard SI. Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. J Lab Clin Med 1990; 115:148-58.
34. Meyer KC, Ershler W, Rosenthal NS, Lu XG, Peterson K. Immune dysregulation in the aging human lung. Am J Respir Crit Care Med 1996; 153:1072-9.
35. Fagnoni FF, Vescovini R, Passeri G etal. Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. Blood 2000; 95:2860-8.
36. Saltini C, Kirby M, Trapnell BC, Tamura N, Crystal RG. Biased accumulation of T lymphocytes with 'memory'-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J Exp Med 1990; 171:1123-40.
37. Cepek KL, Shaw SK, Parker CM etal. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 1994; 372:190-3.
38. Karecla PI, Bowden SJ, Green SJ, Kilshaw PJ. Recognition of E-cadherin on epithelial cells by the mucosal T cell integrin alpha M290 beta 7 (alpha E beta 7). Eur J Immunol 1995; 25:852-6.
39. Bruder D, Westendorf AM, Geffers R etal. CD4 T lymphocyte-mediated lung disease: steady state between pathological and tolerogenic immune reactions. Am J Respir Crit Care Med 2004; 170:1145-52.
40. Wahlstrom J, Berlin M, Skold CM, Wigzell H, Eklund A, Grunewald J. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax 1999; 54:339-46.
41. Heron M, Claessen AM, Grutters JC. Invariant natural killer T cells in obstructive pulmonary diseases. N Engl J Med 2007; 357:194-5.